Molecular targets of interest to the NCI PREVENT cancer preclinical drug development program

被引：0
|
作者：
Shoemaker, R. H. [1 ]
Dunn, B. K. [1 ]
Suen, C. [1 ]
Lubet, R. A. [1 ]
Boring, D. L. [1 ]
Klein, B. D. [1 ]
Miller, M. S. [1 ]
Steele, V. E. [1 ]
机构：
[1] NCI, Canc Prevent Div, Chemoprevent Agent Dev Res Grp, Bethesda, MD 20892 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70351-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
225
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] Animal models in use by the NCI PREVENT Cancer Preclinical Drug Development Program.
    Mohammed, Altaf
    Miller, Mark Steven
    Glaze, Elizabeth
    Fernando, Romaine I.
    Fox, Jennifer
    Lubet, Ronald A.
    Sei, Shizuko
    Shoemaker, Robert H.
    [J]. CANCER RESEARCH, 2018, 78 (10) : 78 - 79
  • [2] Molecular targets drug discovery program, CCR, NCI
    Boyd, MR
    Wiltrout, RH
    Barrett, JC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 61 - 62
  • [3] The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets
    Shoernaker, Robert H.
    Suen, Chen S.
    Holmes, Cathy A.
    Fay, Judith R.
    Steele, Vernon E.
    [J]. SEMINARS IN ONCOLOGY, 2016, 43 (01) : 189 - 197
  • [4] NEW DRUGS IN THE NCI PRECLINICAL DRUG SCREENING AND DEVELOPMENT PROGRAM
    VENDITTI, J
    PLOWMAN, J
    [J]. INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 106 - 106
  • [5] NCI's molecular targets development program (MTDP)
    McMahon, James
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3403S - 3403S
  • [6] NCI/FDA program to streamline cancer drug development
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (08) : 52N - 52N
  • [7] NCI to restructure drug development program
    不详
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (06) : 612 - 613
  • [8] The NCI PREVENT Program portfolio for precision cancer immunoprevention
    Sei, Shizuko
    Mohammed, Altaf
    Fox, Jennifer
    Fernando, Romaine
    Boring, Daniel
    Miller, Mark
    Shoemaker, Robert
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Identification of Drug Targets and Molecular Mechanisms to Prevent Drug Resistance of Cancer Cells
    Satow, Reiko
    Fukami, Kiyoko
    [J]. CANCER SCIENCE, 2018, 109 : 362 - 362
  • [10] Drug Development for Cancer Chemoprevention: Focus on Molecular Targets
    Johnson, Karen A.
    Brown, Powel H.
    [J]. SEMINARS IN ONCOLOGY, 2010, 37 (04) : 345 - 358
12345